A pharmacodynamic trial to investigate A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients who were diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden.
Phase of Trial: Phase II
Latest Information Update: 29 Dec 2015
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Narcolepsy
- Focus Pharmacodynamics
- 29 Dec 2015 New trial record